MatchaDB

2023Prépublication

Effects of matcha tea extract on cell viability and estrogen receptor β expression on MCF7 breast cancer cells

Keckstein S, Tilgener C, jeschke u, Hofmann S, Vilsmaier T, Keilmann L, Heidegger H, Kaltofen T, Batz F, Mahner S, Schröder L

Research Square

Lire chez l'éditeur→

Résumé

Abstract Purpose: In the following work, we investigated the effect of matcha green tea extract (MTE) on MCF-7 breast cancer cell viability and estrogen receptor beta expression (ERβ). Methods: MCF-7 cells were stimulated with MTE at concentrations of 5 and 10 µg/ml. Cell viability was assessed using a WST-1 assay after an incubation time of 72 h. ERβ was quantified at gene level by real-time polymerase chain reaction (PCR). A western blot (WB) was carried out for the qualitative assessment of the expression behavior of on a protein level. Results: The WST-1 test showed a significant inhibition of viability in MFC-7 cells after 72 h at 10 µg/ml. The WB demonstrated a significant quantitative decrease of ERβ at protein level with MTE concentrations of 10 µg/ml. In contrast the PCR did not result in significant downregulation of ERβ. Conclusion: MTE decreases the cell viability of MCF-7 cells and furthermore leads to a decrease of ERβ at protein level.

Le texte du résumé provient de PubMed, OpenAlex ou Europe PMC et appartient aux auteurs et à l'éditeur.

Type d'étude

Chimie / analyse

Mesurer ce que contient le matcha ou comment le détecter.

Attribué automatiquement à partir du titre, du résumé et des termes de sujet.

Thèmes

Le matcha est ici un sujet principal (nommé dans le titre).

Votre dossier de recherche

Citer cette étude

Keckstein S, Tilgener C, jeschke u, Hofmann S, Vilsmaier T, Keilmann L, … Schröder L. (2023). Effects of matcha tea extract on cell viability and estrogen receptor β expression on MCF7 breast cancer cells. Research Square. https://doi.org/10.21203/rs.3.rs-3123368/v1

DOI : 10.21203/rs.3.rs-3123368/v1

Plus sur Cancer

2019Article de revueAccès libre

Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF‑7 and MDA-MB-231 breast carcinoma cells.

Schröder L, Marahrens P, Koch JG, et al. — Oncology reports

We investigated the anticarcinogenic potential of green tea and its components epigallocatechin gallate (EGCG) and quercetin, as well as tamoxifen, on MCF-7 and MDA-MB-23 breast cancer cells. Using high-performance liquid chromatography,…

In vitro / étude cellulaireAntioxydants et polyphénolsCancerInflammation et immunitéCité 84 fois
2018Article de revueAccès libre

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

In vitro / étude cellulaireMétabolisme et poidsAntioxydants et polyphénolsCancerCité 75 fois
1999Article de revue

Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea.

Sato D — International journal of urology : official journal of the Japanese Urological Association

Background: Recently, the anticarcinogenic effects of green tea have been studied in sites other than the urinary tract. The present study examined the inhibition by green tea of vesical tumors induced in rats by N-butyl-N-(4-hydroxybutyl)…

Étude animaleAntioxydants et polyphénolsCancerMétabolisme et poidsCité 44 fois

Parcourir toute la bibliothèque→